Literature DB >> 19047678

Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.

Raquel Malumbres1, Kristopher A Sarosiek, Elena Cubedo, Jose W Ruiz, Xiaoyu Jiang, Randy D Gascoyne, Robert Tibshirani, Izidore S Lossos.   

Abstract

miRNAs are small RNA molecules binding to partially complementary sites in the 3'-UTR of target transcripts and repressing their expression. miRNAs orchestrate multiple cellular functions and play critical roles in cell differentiation and cancer development. We analyzed miRNA profiles in B-cell subsets during peripheral B-cell differentiation as well as in diffuse large B-cell lymphoma (DLBCL) cells. Our results show temporal changes in the miRNA expression during B-cell differentiation with a highly unique miRNA profile in germinal center (GC) lymphocytes. We provide experimental evidence that these changes may be physiologically relevant by demonstrating that GC-enriched hsa-miR-125b down-regulates the expression of IRF4 and PRDM1/BLIMP1, and memory B cell-enriched hsa-miR-223 down-regulates the expression of LMO2. We further demonstrate that although an important component of the biology of a malignant cell is inherited from its nontransformed cellular progenitor-GC centroblasts-aberrant miRNA expression is acquired upon cell transformation. A 9-miRNA signature was identified that could precisely differentiate the 2 major subtypes of DLBCL. Finally, expression of some of the miRNAs in this signature is correlated with clinical outcome of uniformly treated DLBCL patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047678      PMCID: PMC2670792          DOI: 10.1182/blood-2008-10-184077

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Transcriptional analysis of the B cell germinal center reaction.

Authors:  Ulf Klein; Yuhai Tu; Gustavo A Stolovitzky; Jeffrey L Keller; Joseph Haddad; Vladan Miljkovic; Giorgio Cattoretti; Andrea Califano; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

2.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

3.  Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development.

Authors:  Kyongrim Kwon; Caroline Hutter; Qiong Sun; Ivan Bilic; César Cobaleda; Stephen Malin; Meinrad Busslinger
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

4.  The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.

Authors:  Yasodha Natkunam; Shuchun Zhao; David Y Mason; Jun Chen; Behnaz Taidi; Margaret Jones; Anne S Hammer; Stephen Hamilton Dutoit; Izidore S Lossos; Ronald Levy
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

5.  The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.

Authors:  Y Yamada; A J Warren; C Dobson; A Forster; R Pannell; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.

Authors:  Anja Roehle; Kai P Hoefig; Dirk Repsilber; Christoph Thorns; Marita Ziepert; Kai O Wesche; Marlen Thiere; Markus Loeffler; Wolfram Klapper; Michael Pfreundschuh; András Matolcsy; Heinz-Wolfram Bernd; Lila Reiniger; Hartmut Merz; Alfred C Feller
Journal:  Br J Haematol       Date:  2008-06-03       Impact factor: 6.998

8.  miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.

Authors:  Lin Xia; Dexin Zhang; Rui Du; Yanglin Pan; Lina Zhao; Shiren Sun; Liu Hong; Jie Liu; Daiming Fan
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

9.  MicroRNA expression in lymphocyte development and malignancy.

Authors:  C H Lawrie; N J Saunders; S Soneji; S Palazzo; H M Dunlop; C D O Cooper; P J Brown; X Troussard; H Mossafa; T Enver; F Pezzella; J Boultwood; J S Wainscoat; C S R Hatton
Journal:  Leukemia       Date:  2008-01-10       Impact factor: 11.528

10.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Authors:  Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavally V Murty; Margaret A Shipp; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2006-02-20       Impact factor: 14.307

View more
  116 in total

1.  CFTR mediates bicarbonate-dependent activation of miR-125b in preimplantation embryo development.

Authors:  Yong Chao Lu; Hui Chen; Kin Lam Fok; Lai Ling Tsang; Mei Kuen Yu; Xiao Hu Zhang; Jing Chen; Xiaohua Jiang; Yiu Wa Chung; Alvin Chun Hang Ma; Anskar Yu Hung Leung; He Feng Huang; Hsiao Chang Chan
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

2.  miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.

Authors:  Shaun Willimott; Simon D Wagner
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

3.  Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.

Authors:  Richard Danger; Annaïck Pallier; Magali Giral; Marc Martínez-Llordella; Juan José Lozano; Nicolas Degauque; Alberto Sanchez-Fueyo; Jean-Paul Soulillou; Sophie Brouard
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

4.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

5.  HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway.

Authors:  Xiaoyu Jiang; Xiaoqing Lu; George McNamara; Xiaofei Liu; Elena Cubedo; Kristopher A Sarosiek; Isidro Sánchez-García; David M Helfman; Izidore S Lossos
Journal:  Blood       Date:  2010-09-15       Impact factor: 22.113

6.  Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.

Authors:  Dereje D Jima; Jenny Zhang; Cassandra Jacobs; Kristy L Richards; Cherie H Dunphy; William W L Choi; Wing Yan Au; Gopesh Srivastava; Magdalena B Czader; David A Rizzieri; Anand S Lagoo; Patricia L Lugar; Karen P Mann; Christopher R Flowers; Leon Bernal-Mizrachi; Kikkeri N Naresh; Andrew M Evens; Leo I Gordon; Micah Luftig; Daphne R Friedman; J Brice Weinberg; Michael A Thompson; Javed I Gill; Qingquan Liu; Tam How; Vladimir Grubor; Yuan Gao; Amee Patel; Han Wu; Jun Zhu; Gerard C Blobe; Peter E Lipsky; Amy Chadburn; Sandeep S Dave
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

Review 7.  Pathogenesis of diffuse large B cell lymphoma.

Authors:  Wing John C Chan
Journal:  Int J Hematol       Date:  2010-06-29       Impact factor: 2.490

Review 8.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

9.  MicroRNA-125b potentiates macrophage activation.

Authors:  Aadel A Chaudhuri; Alex Yick-Lun So; Nikita Sinha; William S J Gibson; Konstantin D Taganov; Ryan M O'Connell; David Baltimore
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

10.  Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles.

Authors:  Shipra Malik; Jihoon Lim; Frank J Slack; Demetrios T Braddock; Raman Bahal
Journal:  J Control Release       Date:  2020-08-21       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.